(Q83176582)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20221624%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Intravitreal bevacizumab to treat myopic choroidal neovascularization: 2-year outcome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20221624%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

Jose M Ruiz-Moreno

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20221624%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Javier A Montero

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20221624%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

10 March 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20221624%20AND%20SRC:MED&resulttype=core&format=json

Graefe's Archive for Clinical and Experimental Ophthalmology

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20221624%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

248

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20221624%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20221624%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

937-941

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20221624%20AND%20SRC:MED&resulttype=core&format=json

Two-year comparison of photodynamic therapy and intravitreal bevacizumab for treatment of myopic choroidal neovascularisation

19 January 2020

cites work

1 reference

12 December 2020

Long-term visual acuity after argon green laser photocoagulation of juxtafoveal choroidal neovascularization in highly myopic eyes.

1 reference

12 December 2020

Choroidal neovascularization in pathologic myopia: three-year results after photodynamic therapy

1 reference

12 December 2020

Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia

1 reference

12 December 2020

Intravitreal ranibizumab (Lucentis) for the treatment of myopic choroidal neovascularization

1 reference

12 December 2020

Photodynamic therapy to treat choroidal neovascularisation in highly myopic patients: 4 years' outcome

1 reference

12 December 2020

Intravitreal bevacizumab (Avastin) as primary treatment for myopic choroidal neovascularization

1 reference

12 December 2020

Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia

1 reference

12 December 2020

Intravitreal bevacizumab for choroidal neovascularization attributable to pathological myopia: one-year results.

1 reference

12 December 2020

Anty-VEGF therapy in the treatment of myopic macular choroidal neovascularization--cases report

1 reference

12 December 2020

Etiology of choroidal neovascularization in young patients

1 reference

12 December 2020

Bevacizumab suppresses choroidal neovascularisation caused by pathological myopia.

1 reference

12 December 2020

Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study

1 reference

12 December 2020

Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularisation: 1-year results of a prospective pilot study

1 reference

12 December 2020

Treatment of choroidal neovascularization in pathologic myopia with intravitreal bevacizumab

1 reference

12 December 2020

SHORT-TERM EFFICACY AND SAFETY OF INTRAVITREAL RANIBIZUMAB FOR MYOPIC CHOROIDAL NEOVASCULARIZATION

1 reference

12 December 2020

Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization

1 reference

12 December 2020

Intravitreal injection of bevacizumab for myopic choroidal neovascularization: 1-year follow-up

1 reference

12 December 2020

Pegaptanib for myopic choroidal neovascularization in a young patient

1 reference

12 December 2020

Intravitreal bevacizumab treatment for choroidal neovascularization in pathologic myopia: 12-month results

1 reference

12 December 2020

Intravitreous bevacizumab to treat subfoveal choroidal neovascularization in highly myopic eyes: short-term results

1 reference

12 December 2020

Ranibizumab: Phase III clinical trial results

1 reference

12 December 2020

Intravitreal bevacizumab (Avastin) for choroidal neovascularisation secondary to pathological myopia: 6-month results.

1 reference

12 December 2020

Subretinal fibrosis after photodynamic therapy in subfoveal choroidal neovascularisation in highly myopic eyes

1 reference

12 December 2020

Intravitreal bevacizumab to treat subfoveal choroidal neovascularisation in highly myopic eyes: 1-year outcome

1 reference

12 December 2020

Intravitreal bevacizumab for treatment of choroidal neovascularization in pathologic myopia

1 reference

12 December 2020

Two-year visual results for older Asian women treated with photodynamic therapy or bevacizumab for myopic choroidal neovascularization.

1 reference

12 December 2020